Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2023

The global COVID-19 pandemic had a slight negative impact on the Latin America IC market in the short term. The market will grow moderately through 2031, with the expanding CAD procedure volume and increasing adoption of advanced devices, especially in the coronary stent segment. However, the market is limited by the lack of reimbursement and continuing budgetary constraints among Latin American facilities leading to inhibit the uptake of high-cost products.

This Medtech 360 Report provides high-level market metrics for interventional cardiology devices in the Latin American region, including country-level data for major countries and aggregate data for the rest of the Latin America from 2019 through 2031.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Spinal Implants – Market Insights – Latin America
The Latin American spinal implant market will grow over the forecast period, driven by an aging population, rising demand for minimally invasive procedures, and strategic mergers and acquisitions…